| 前收市價 | 85.00 |
| 開市 | 85.47 |
| 買盤 | 67.80 x 無 |
| 賣出價 | 98.50 x 無 |
| 今日波幅 | 82.85 - 88.80 |
| 52 週波幅 | 62.00 - 171.80 |
| 成交量 | |
| 平均成交量 | 2,298,006 |
| 市值 | 821.493M |
| Beta 值 (5 年，每月) | 0.01 |
| 市盈率 (最近 12 個月) | 8.54 |
| 每股盈利 (最近 12 個月) | 0.10 |
| 業績公佈日 | 2024年5月30日 |
| 遠期股息及收益率 | 0.06 (6.87%) |
| 除息日 | 2024年1月04日 |
| 1 年預測目標價 | 75.77 |
ReutersMarathon Partners urges Dr Martens to buy back stock, detail expense cuts
BOSTON (Reuters) -Investment firm Marathon Partners Equity Management is turning up the heat on Dr Martens by urging the British boot maker to detail planned expense cuts and to buy back stock, people familiar with the matter told Reuters. The increased pressure comes roughly two months after Marathon Partners' managing member Mario Cibelli suggested Dr Martens launch a strategic review that could lead to its sale, arguing it was the best way forward for the company, whose chunky lace-up boots have been a fashion statement since the 1960s. Cibelli has told executives it would be sensible for Dr Martens to lay out specific plans when it announces earnings on May 30, which are expected to be in line with previously issued guidance, the sources said.
FortuneGen Z favorite Dr. Martens is struggling as its CEO steps down—and it might be because their shoes last too long
Famously made to last, the durability that led to its popularity may be the very thing keeping it from astronomic growth.
AASTOCKS英國皮靴品牌Dr Martens料2025財年前景具挑戰 股價一度跌30%
英國皮靴品牌Dr Martens預期2025財年前景具有挑戰，但2024財年表現將會符合預期，在倫敦股價曾急跌30%至歷史新低，並一度暫停交易。公司宣布，行政總裁Kenny Wilson將於明年3月離任，由首席品牌總監Ije Nwokorie接任。
